Alexandria Real Estate Equities Celebrates 20 Years of Prix Galien USA Partnership
Alexandria Real Estate Equities (NYSE: ARE) is marking the 20th anniversary of its partnership with the Galien Foundation and the Prix Galien USA in New York City. The company continues to play a central role in the NYC life science ecosystem through its Megacampus™ developments and strategic venture investments via Alexandria Venture Investments (AVI). A key highlight is the Multi-Modal Assessment and Phenotyping in Depression (MAP-D) initiative, a public-private partnership between Alexandria and the Foundation for the National Institutes of Health (FNIH). The initiative has moved into a three-year pilot phase using artificial intelligence to create a precision medicine framework for depression research. Alexandria also highlighted its historical success in venture capital, noting that its early investment in Intra-Cellular Therapies, Inc. (ITCI) contributed to the company's $14.6 billion acquisition by Johnson & Johnson in 2025.
Tickers: $ALTO $ANRO $ARE $JNJ $LLY
Topics: Corporate Anniversary Life Science Ecosystems Neuroscience Research Strategic Partnership